Literature DB >> 19427776

Characteristics of patients admitted for the first time for COPD exacerbation.

Eva Balcells1, Josep M Antó, Joaquim Gea, Federico P Gómez, Esther Rodríguez, Alicia Marin, Antoni Ferrer, Jordi de Batlle, Eva Farrero, Marta Benet, Mauricio Orozco-Levi, Jaume Ferrer, Alvar G Agustí, Juan B Gáldiz, José Belda, Judith Garcia-Aymerich.   

Abstract

BACKGROUND: This study describes the characteristics of a large sample of patients hospitalised for the first time for a chronic obstructive pulmonary disease (COPD) exacerbation.
METHODS: All subjects first admitted for a COPD exacerbation to nine teaching Spanish hospitals during January 2004-March 2006, were eligible. COPD diagnosis was confirmed by spirometry under stability. At admission, sociodemographic data, lifestyle, previous treatment and diagnosis of respiratory disease, lung function and Charlson index of co-morbidity were collected. A comprehensive assessment, including dyspnea, lung function, six-minute walking test, and St. George's Respiratory Questionnaire (SGRQ), was completed 3 months after admission, during a clinically stable disease period.
RESULTS: Three-hundred and forty-two patients (57% of the eligible) participated in the study: 93% males, mean (SD) age 68 (9) years, 42% current smokers, 50% two or more co-morbidities, 54% mild-to-moderate dyspnea, post-bronchodilator FEV(1) 52 (16)% of predicted (54% mild-to-moderate COPD in ATS/ERS stages), 6-min walking distance 440 m, total SGRQ score 37 (18), and 36% not report respiratory disease. The absence of a previous COPD diagnosis, positive bronchodilator test, female gender, older age, higher DLco and higher BMI were independently associated with less severe COPD.
CONCLUSIONS: We show that the patients admitted after presenting with their first COPD exacerbation have a wide range of severity, with a large proportion of patients in the less advanced COPD stages.

Entities:  

Mesh:

Year:  2009        PMID: 19427776     DOI: 10.1016/j.rmed.2009.04.001

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  19 in total

1.  Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts.

Authors:  Peter J Castaldi; Marta Benet; Hans Petersen; Nicholas Rafaels; James Finigan; Matteo Paoletti; H Marike Boezen; Judith M Vonk; Russell Bowler; Massimo Pistolesi; Milo A Puhan; Josep Anto; Els Wauters; Diether Lambrechts; Wim Janssens; Francesca Bigazzi; Gianna Camiciottoli; Michael H Cho; Craig P Hersh; Kathleen Barnes; Stephen Rennard; Meher Preethi Boorgula; Jennifer Dy; Nadia N Hansel; James D Crapo; Yohannes Tesfaigzi; Alvar Agusti; Edwin K Silverman; Judith Garcia-Aymerich
Journal:  Thorax       Date:  2017-06-21       Impact factor: 9.139

2.  Do symptoms predict COPD in smokers?

Authors:  Jill A Ohar; Alireza Sadeghnejad; Deborah A Meyers; James F Donohue; Eugene R Bleecker
Journal:  Chest       Date:  2010-04-02       Impact factor: 9.410

Review 3.  Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations.

Authors:  Joaquim Gea; Antoni Sancho-Muñoz; Roberto Chalela
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

4.  Disability Retirement After First Admission with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Danish Nationwide Registry Cohort Study Using a Retrospective Follow-Up Design.

Authors:  Peter Ascanius Jacobsen; Kristian Kragholm; Christian Torp-Pedersen; Ulla Møller Weinreich
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-10-11

5.  Validation and Assessment of the COPD Treatment Ratio as a Predictor of Severe Exacerbations.

Authors:  Richard H Stanford; Stephanie Korrer; Lee Brekke; Tyler Reinsch; Lindsay G S Bengtson
Journal:  Chronic Obstr Pulm Dis       Date:  2020-01

6.  Factors affecting the relationship between psychological status and quality of life in COPD patients.

Authors:  Eva Balcells; Joaquim Gea; Jaume Ferrer; Ignasi Serra; Mauricio Orozco-Levi; Jordi de Batlle; Esther Rodriguez; Marta Benet; David Donaire-González; Josep M Antó; Judith Garcia-Aymerich
Journal:  Health Qual Life Outcomes       Date:  2010-09-27       Impact factor: 3.186

7.  Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation.

Authors:  Eva Balcells; Elena Gimeno-Santos; Jordi de Batlle; Maria Antonia Ramon; Esther Rodríguez; Marta Benet; Eva Farrero; Antoni Ferrer; Stefano Guerra; Jaume Ferrer; Jaume Sauleda; Joan A Barberà; Àlvar Agustí; Robert Rodriguez-Roisin; Joaquim Gea; Josep M Antó; Judith Garcia-Aymerich
Journal:  BMC Pulm Med       Date:  2015-01-17       Impact factor: 3.317

Review 8.  New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analyses.

Authors:  Douglas W Mapel; Melissa H Roberts
Journal:  Pharmacoeconomics       Date:  2012-10-01       Impact factor: 4.981

9.  Specific IgA and metalloproteinase activity in bronchial secretions from stable chronic obstructive pulmonary disease patients colonized by Haemophilus influenzae.

Authors:  Laura Millares; Alicia Marin; Judith Garcia-Aymerich; Jaume Sauleda; José Belda; Eduard Monsó
Journal:  Respir Res       Date:  2012-12-11

10.  Lifetime occupational exposure to dusts, gases and fumes is associated with bronchitis symptoms and higher diffusion capacity in COPD patients.

Authors:  Esther Rodríguez; Jaume Ferrer; Jan-Paul Zock; Ignasi Serra; Josep M Antó; Jordi de Batlle; Hans Kromhout; Roel Vermeulen; David Donaire-González; Marta Benet; Eva Balcells; Eduard Monsó; Angel Gayete; Judith Garcia-Aymerich
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.